Sensus Healthcare Inc logo

Sensus Healthcare Inc

2
NAS:SRTS (USA)  
$ 5.29 +1.48 (+38.85%) 10:09 PM EST
176.33
P/B:
1.77
Market Cap:
$ 86.72M
Enterprise V:
$ 64.36M
Volume:
19.66M
Avg Vol (2M):
584.68K
Also Trade In:
Volume:
19.66M
Avg Vol (2M):
584.68K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for SRTS ( Sensus Healthcare Inc ) from 2016 to May 12 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sensus Healthcare stock (SRTS) PE ratio as of May 12 2024 is 176.33. More Details

Sensus Healthcare Inc (SRTS) PE Ratio (TTM) Chart

To

Sensus Healthcare Inc (SRTS) PE Ratio (TTM) Historical Data

Total 1227
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Sensus Healthcare PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-12 176.3 2024-03-08 138.7
2024-05-10 176.3 2024-03-07 134.8
2024-05-09 127.0 2024-03-06 135.7
2024-05-08 127.7 2024-03-05 135.3
2024-05-07 126.0 2024-03-04 135.3
2024-05-06 125.3 2024-03-01 137.7
2024-05-03 121.7 2024-02-29 136.7
2024-05-02 128.7 2024-02-28 149.7
2024-05-01 120.3 2024-02-27 153.0
2024-04-30 125.3 2024-02-26 151.7
2024-04-29 113.0 2024-02-23 162.0
2024-04-26 113.7 2024-02-22 157.7
2024-04-25 111.0 2024-02-21 155.7
2024-04-24 109.3 2024-02-20 163.7
2024-04-23 113.3 2024-02-16 157.0
2024-04-22 113.0 2024-02-15 135.0
2024-04-19 109.7 2024-02-14 143.0
2024-04-18 108.3 2024-02-13 144.0
2024-04-17 108.3 2024-02-12 140.0
2024-04-16 106.7 2024-02-09 129.3
2024-04-15 106.7 2024-02-08 121.7
2024-04-12 112.7 2024-02-07 121.3
2024-04-11 104.7 2024-02-06 116.3
2024-04-10 111.7 2024-02-05 108.0
2024-04-09 115.0 2024-02-02 105.3
2024-04-08 119.3 2024-02-01 108.0
2024-04-05 115.0 2024-01-31 108.3
2024-04-04 114.7 2024-01-30 110.3
2024-04-03 118.0 2024-01-29 115.3
2024-04-02 115.7 2024-01-26 117.7
2024-04-01 126.3 2024-01-25 119.0
2024-03-28 126.7 2024-01-24 117.3
2024-03-27 130.7 2024-01-23 112.0
2024-03-26 133.0 2024-01-22 88.7
2024-03-25 125.3 2024-01-19 87.0
2024-03-22 125.7 2024-01-18 90.3
2024-03-21 127.0 2024-01-17 94.7
2024-03-20 122.3 2024-01-16 95.3
2024-03-19 128.3 2024-01-12 90.7
2024-03-18 120.0 2024-01-11 88.3
2024-03-15 117.3 2024-01-10 92.0
2024-03-14 123.3 2024-01-09 95.7
2024-03-13 129.7 2024-01-08 89.3
2024-03-12 118.3 2024-01-05 87.7
2024-03-11 113.3 2024-01-04 85.2

Sensus Healthcare Inc (SRTS) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.